The 3D screen print­ing tech­nol­ogy of Laxxon Med­ical Corp. pro­vides phar­ma­ceu­ti­cal com­pa­nies with new, pre­vi­ously unknown pos­si­bil­i­ties for opti­mized and inno­v­a­tive drug deliv­ery sys­tems (DDS) for their prod­uct devel­op­ment and pro­duc­tion processes.